Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Disease Search Button

NETS - Re-evaluate or Discontinue

Facebook icon
Twitter icon
LinkedIn icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What is "re-evaluate or discontinue" and why is it important in drug development?

If new data or evidence that shows an approved drug has dangerous risks associated with its use or is ineffective, the drug may be re-evaluated by the health administration. They will look at the new evidence and decide whether the evidence is valid and if the drug should be discontinued. A drug is discontinued when the health administration revokes their approval or decides to stop a clinical trial of the drug. When this happens, the compound will no longer be available for use in humans.

Testimonials: How we did it

Content not yet available for this section.

Related Tools

Content not yet available for this section.


Follow Us

Twitter icon
Facebook icon
LinkedIn icon
YouTube icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.